β-Estradiol attenuate amyloid β-peptide toxicity via nicotinic receptors

NeuroReport

Volumn 10, Issue 17, 1999, Pages 3485-3489

  Svensson, A L ^a   Nordberg, A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Donepezil; Estradiol; Neuroprotection; Nicotinic receptors; PC 12 cells; Tacrine; Amyloid(25 35)

Indexed keywords

AMYLOID BETA PROTEIN; CHOLINESTERASE INHIBITOR; DONEPEZIL; EPIBATIDINE; ESTRADIOL; MECAMYLAMINE; METHYLLYCACONITINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; TACRINE;

ANIMAL CELL; ARTICLE; BRAIN PROTECTION; CELL STRAIN; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0033607705     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199911260-00004     Document Type: Article

References (27)

1. 1. Henderson VW. CNS Drugs 8, 343-351 (1997).
2. 2 Yaffe K, Sawaya G, Lieberburg I and Grady D. JAMA 279, 688-695 (1998).
3. 3. Schneider LS, Farlow MR, Henderson VW and Pogoda JM. Neurology 46, 1580-1584 (1996).
4. 4. Wickelgren I. Science 276, 675-678 (1997).
5. 5. Inestrosa NC, Marzolo M-P and Bonnefont AB. Mol Neurobiol 17, 73-86 (1998).
6. 6. Luine VN, Park D, Joh T et al. Brain Res 191, 273-277 (1980).
7. 7. Singh M, Meyer EM, Huang FS et al Abstr Soc Neurosci 19, 1254 (1993).
8. 8. Green PS, Gridley KE and Simpkins JW. Neurosci Lett 218, 165-168 (1996).
9. 9. Behl C, Skutella T, Lezoualc'h F et al. Mol Pharmacol 51, 535-541 (1997).
10. 10. Xu H, Gouras GK, Greenfield JP et al. Nature Med 4, 447-451 (1998).
11. 11. Greene LA and Tischler A. Proc Natl Acad Sci USA 73, 2424-2428 (1976).
12. 12. Lowry OH, Rosenbrough NJ, Farr AL and Randall RJ. J Biol Chem 193, 265-275 (1951).
13. 13. Hansen MB, Nielsen SE and Berg K. J Immunol Methods 119, 203-210 (1989).
14. 14. Green PS, Bishop J and Simpkins JW, J Neurosci 17, 511-515 (1997).
15. 15. Behl C, Widmann M, Trapp T and Hoisboer F. Biochem Biophys Res Commun 216, 473-482 (1995).
16. 16. Bonnefont AB, Munoz FJ and Inestrosa NC, FEBS Lett 441, 220-224 (1998).
17. 17. Kinara T, Shimihama S, Sawada H et al. Ann Neurol 42, 159-163 (1997).
18. 18. Zamani M, Allen Y, Owen G et al. Neuroreport 8, 523-527 (1997).
19. 19. Svensson A and Nordberg A. Neuroreport 9, 1519-1522 (1998).
20. 20 Davies AL, Hardick DJ, Blagbrough IS et al. Neuropharmacology 38, 679-690 (1999).
21. 21. Ke L and Lukas RJ. J Neurochem 67, 1100-1112 (1996).
22. 22. Valera S, Ballivet M and Bertrand D. Proc Natl Acad Sci USA 89, 9949-9953 (1992).
23. 23. Schrattenholz A, Pereira EFR, Roth U et al. Mol. Pharmacol 49, 1-6 (1996).
24. 24. Svensson A and Nordberg A. Neuroreport, 2201-2205 (1996).
25. 25. Maelicke A, Coban T, Storch A et al. J Receptor Signal Transd Res 17, 11-28 (1997)
26. 26. Bullock AB, Clark AL, Grady SR et al. J Neurochem 68, 2412-2423 (1997).
27. 27. Uki M, Nabekura J and Akaike N. J Neurochem 72, 808-814 (1999).